Alexander Introduces Pharmaceutical Compounding Legislation

Wednesday, May 15, 2013

Chairman of the Senate Health, Education, Labor and Pensions Committee Senator Tom Harkin (D-Iowa) and Ranking Member Lamar Alexander (R-Tn.), with Senators Pat Roberts (R-Ks.) and Al Franken (D-Mn.) and other members of the HELP Committee, on Wednesday introduced legislation—the Pharmaceutical Compounding Quality and Accountability Act—that would improve the safety of compounded human and animal drugs by making clear the compounding oversight responsibilities of state and federal authorities. 

Chairman Harkin and Ranking Member Alexander also announced that the Committee will convene for an executive session next Wednesday, to consider the compounding bill, along with newly-introduced legislation to strengthen and improve the drug distribution supply chain.

In April, Senators Harkin, Alexander, Roberts, and Franken released draft legislation relating to pharmaceutical compounding and requested that stakeholders provide feedback on the policy merits, potential unintended consequences, and opportunities to improve the legislative language. Additionally, the HELP Committee held a legislative hearing in early May to listen to more in-depth testimonies from experts and stakeholders to improve the draft bill.  An updated one-pager, section-by-section and the Pharmaceutical Compounding Quality and Accountability Act can be viewed on the HELP Committee website.

The Pharmaceutical Compounding Quality and Accountability Act makes a clear distinction between traditional compounding—which will continue to be regulated primarily by state pharmacy boards—and compounding manufacturers that make sterile products without, or in advance of, a prescription and sell those products across state lines. The compounding manufacturers would be regulated by the U.S. Food and Drug Administration (FDA). It clarifies a national, uniform set of rules for compounding manufacturers while preserving the states’ primary role in traditional pharmacy regulation.

“We cannot wait for the next public health crisis—as we saw with the New England Compounding Company disaster that led to more than 50 deaths and caused serious illness in 700 more—to act to improve the safety of compounded drugs,” Chairman Harkin said. “The Pharmaceutical Compounding Quality and Accountability Act will help protect the public from unsafe compounded products and clarify FDA authority over high-risk compounding practices. I am proud of the bipartisan effort that members of this Committee have put forth in drafting this bill, and I am appreciative of the helpful and constructive feedback received from stakeholders throughout this process. I look forward to considering this bill in an executive session of the Committee next week.”

Senator Alexander said, “My primary goal with this legislation is to erase the confusion over who regulates pharmacies and manufacturing facilities, and make it clear exactly who oversees each business. Putting one agency on the flagpole for each of these businesses will mean greater safety for American families, so they don’t have to question whether the drugs they take are safe.”

“I am proud of the work we have done to craft a solution that protects patients, while preserving the practice of traditional pharmacy compounding,” Senator Roberts said. “After reviewing stakeholder comments, we made a concerted effort to address their concerns in this legislation. This bipartisan bill is balanced, clear and will leave no questions about the regulatory oversight of compounded drugs. I urge my colleagues to support it.”

"We've seen far too many deaths in Minnesota, and nationwide, because some pharmacies in this country have acted more like drug manufacturers – without following rigorous safety rules that drug manufacturers must follow,” said Senator Franken. “This bipartisan legislation will keep Minnesotans safe by ensuring that drug manufacturers have appropriate oversight, and that responsible pharmacies don't see any unnecessary restrictions."

In addition to distinguishing between pharmacies and manufacturers, and clarifying proper oversight of each, the legislation sets forth requirements on compounding manufacturers. Compounding manufacturers must register with the FDA and tell the agency what products they have made; make products under a pharmacist’s oversight and in compliance with good manufacturing practices; and investigate and report when things go wrong.

The bill allows FDA to identify categories of drugs that currently cannot be safely compounded; preserves and enhances current protections regarding the ingredients from which drugs are compounded; and preserves the line between compounding manufacturers and traditional manufacturers by placing prohibitions on wholesale distribution of compounded products.

The legislation also encourages communication among states and increases communication between states and the FDA. FDA will designate a point of contact for a State Board of Pharmacy to notify the agency if it appears that a state-licensed business should be registered as a compounding pharmacy. The FDA must notify the state within 15 days if it determines that business is a compounding manufacturer.



Local Publix Stores Raise Over $25,000 For New Children’s Hospital At Erlanger

Publix Super Markets customers and associates in Chattanooga and Cleveland wrapped up their 26th annual Miracle Balloon campaign, raising $25,396 for the new Children’s Hospital at Erlanger.  From June 10-July 1, Publix team members sold Children’s Miracle Network Hospitals’ Miracle Balloons coupons at the register.  Funds raised by local Publix locations will go directly ... (click for more)

5 Governors To Testify At Hearing On Stabilizing Premiums In The Individual Market

Senate health committee Chairman Lamar Alexander and Ranking Member Patty Murray (D-Wash.) Wednesday announced the Senate health committee will hear Sept. 7 from governors representing the states of Massachusetts, Montana, Tennessee, Utah and Colorado.  They are Governor Charlie Baker of Massachusetts, Governor Steve Bullock of Montana, Governor Bill Haslam of Tennessee, Governor ... (click for more)

TVA Budget Remains Flat For FY 2018; Includes 1.5 Percent Retail Rate Increase

The Tennessee Valley Authority Board of Directors on Wednesday approved a $10.37 billion budget that will keep TVA on track to achieving its long-range goals of improving financial and operational performance and reducing debt. The FY 2018 budget keeps operating and maintenance spending flat, maintains low energy costs and invests in TVA’s generation and transmission systems.  ... (click for more)

Mae Beavers Resigns From State Senate To Focus On Governor Race

Tennessee State Senator and conservative Republican candidate for Governor Mae Beavers has announced that she will resign her seat in the legislature effective Friday , Sept. 1,  at noon to focus on her race for governor .   She also disclosed key additions to her gubernatorial campaign team. “It is with mixed emotions that I am announcing that ... (click for more)

Is This Really About Slavery?

The greatest thing that came out of the American Civil War came after the cessation of hostilities. After four years of deadly, devastating, agonizing war and over 600,000 Americans had died, the armies came to a halt. The killing ended, but the suffering continued for many of the wounded and those whose homes and fortunes had gone up in smoke and been left as rubble. ... (click for more)

Roy Exum: Ordinary To Extraordinary

A handsome black guy, from the looks of it still in high school, appeared in a video during the A Celebration of Valor luncheon at the Chattanooga Convention Center Tuesday afternoon and described a Medal of Honor winner. Easily over 500 were there, including our famed Charles Coolidge, and all heard this young achiever say, “A Medal recipient is an ordinary person who performs ... (click for more)